FN1 and neoplasm: We have shown that systemic treatment of PDAC with RGD-ELNP/miR-200c significantly elevated the level of miR-200c in PDAC tumors and modulated tumor ECM by downregulating EDB-FN expression, resulting in tumor growth inhibition and extended survival.